BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 21691915)

  • 41. Insomnia in generalized anxiety disorder: polysomnographic, psychometric and clinical investigations before, during and after therapy with a long- versus a short-half-life benzodiazepine (quazepam versus triazolam).
    Saletu B; Anderer P; Brandstätter N; Frey R; Grünberger J; Klösch G; Mandl M; Wetter T; Zeitlhofer J
    Neuropsychobiology; 1994; 29(2):69-90. PubMed ID: 8170529
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Safety of ramelteon in individuals with mild to moderate obstructive sleep apnea.
    Kryger M; Wang-Weigand S; Roth T
    Sleep Breath; 2007 Sep; 11(3):159-64. PubMed ID: 17294232
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Sleep laboratory study of the effects of midazolam in insomniac patients.
    Monti JM; Debellis J; Gratadoux E; Alterwain P; Altier H; D'Angelo L
    Eur J Clin Pharmacol; 1982; 21(6):479-84. PubMed ID: 7075654
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Insomnia: Neurophysiological and neuropsychological approaches.
    Bastien CH
    Neuropsychol Rev; 2011 Mar; 21(1):22-40. PubMed ID: 21249453
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Zopiclone versus triazolam in insomniac geriatric patients: a specific increase in delta sleep with zopiclone.
    Mouret J; Ruel D; Maillard F; Bianchi M
    Int Clin Psychopharmacol; 1990 Apr; 5 Suppl 2():47-55. PubMed ID: 2201730
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Biological models of depression: effect of antidepressants on sleep].
    Viot-Blanc V
    Encephale; 1995 Dec; 21 Spec No 7():35-40. PubMed ID: 8929677
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A single-dose, randomized, double-blind, double dummy, placebo and positive-controlled, five-way cross-over study to assess the pharmacodynamic effects of lorediplon in a phase advance model of insomnia in healthy Caucasian adult male subjects.
    Horoszok L; Baleeiro T; D'Aniello F; Gropper S; Santos B; Guglietta A; Roth T
    Hum Psychopharmacol; 2014 May; 29(3):266-73. PubMed ID: 24911577
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Polysomnographic structure of subjective "awake" and "asleep" nocturnal segments].
    Kraemer S; Ziller M
    Wien Med Wochenschr; 1995; 145(17-18):481-2. PubMed ID: 8588376
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Energy expenditure in obstructive sleep apnea: validation of a multiple physiological sensor for determination of sleep and wake.
    O'Driscoll DM; Turton AR; Copland JM; Strauss BJ; Hamilton GS
    Sleep Breath; 2013 Mar; 17(1):139-46. PubMed ID: 22318784
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hypnotic effectiveness of sodium salicylamide with short-term use: sleep laboratory studies.
    Soldatos CR; Kales A; Bixler EO; Scharf MB; Kales JD
    Pharmacology; 1978; 16(4):193-8. PubMed ID: 345289
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Polygraphical sleep recordings in insomniac patients under zopiclone or nitrazepam.
    Jovanovic UJ; Dreyfus JF
    Int Pharmacopsychiatry; 1982; 17 Suppl 2():136-45. PubMed ID: 7188371
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Opioid use, pain intensity, age, and sleep architecture in patients with fibromyalgia and insomnia.
    Curtis AF; Miller MB; Rathinakumar H; Robinson M; Staud R; Berry RB; McCrae CS
    Pain; 2019 Sep; 160(9):2086-2092. PubMed ID: 31180977
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Characterising insomnia: A graph spectral theory approach.
    Chaparro-Vargas R; Ahmed B; Penzel T; Cvetkovic D
    Annu Int Conf IEEE Eng Med Biol Soc; 2015; 2015():366-9. PubMed ID: 26736275
    [TBL] [Abstract][Full Text] [Related]  

  • 54. An assessment of the efficacy and safety of eszopiclone in the treatment of transient insomnia in healthy adults.
    Rosenberg R; Caron J; Roth T; Amato D
    Sleep Med; 2005 Jan; 6(1):15-22. PubMed ID: 15680290
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The tryptophan depletion test: impact on sleep in primary insomnia - a pilot study.
    Riemann D; Feige B; Hornyak M; Koch S; Hohagen F; Voderholzer U
    Psychiatry Res; 2002 Mar; 109(2):129-35. PubMed ID: 11927137
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Diagnosis and management of sleep disorders.
    Townsend JB
    Del Med J; 1991 Sep; 63(9):525-34. PubMed ID: 1756891
    [No Abstract]   [Full Text] [Related]  

  • 57. A randomized, double-blind, single-dose, placebo-controlled, multicenter, polysomnographic study of gabapentin in transient insomnia induced by sleep phase advance.
    Rosenberg RP; Hull SG; Lankford DA; Mayleben DW; Seiden DJ; Furey SA; Jayawardena S; Roth T
    J Clin Sleep Med; 2014 Oct; 10(10):1093-100. PubMed ID: 25317090
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Evaluation of different tests based on observations for external model evaluation of population analyses.
    Brendel K; Comets E; Laffont C; Mentré F
    J Pharmacokinet Pharmacodyn; 2010 Feb; 37(1):49-65. PubMed ID: 20033477
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Standardized visual predictive check versus visual predictive check for model evaluation.
    Wang DD; Zhang S
    J Clin Pharmacol; 2012 Jan; 52(1):39-54. PubMed ID: 21257797
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hypnotics and sleep physiology: a consensus report. European Sleep Research Society, Committee on Hypnotics and Sleep Physiology.
    Borbély AA; Akerstedt T; Benoit O; Holsboer F; Oswald I
    Eur Arch Psychiatry Clin Neurosci; 1991; 241(1):13-21. PubMed ID: 1679666
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.